| 000 | 01487 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515100714.0 | ||
| 264 | 0 | _c20080116 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1528-1159 | ||
| 024 | 7 |
_a10.1097/BRS.0b013e318157393e _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAl-Nammari, Shafic Said | |
| 245 | 0 | 0 |
_aHematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis. _h[electronic resource] |
| 260 |
_bSpine _cOct 2007 |
||
| 300 |
_a2480-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aDiscitis _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeurosurgical Procedures _xstatistics & numerical data |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSepsis _xmicrobiology |
| 650 | 0 | 4 | _aSex Distribution |
| 650 | 0 | 4 |
_aSpine _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
| 700 | 1 | _aLucas, Jonathan D | |
| 700 | 1 | _aLam, Khai S | |
| 773 | 0 |
_tSpine _gvol. 32 _gno. 22 _gp. 2480-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/BRS.0b013e318157393e _zAvailable from publisher's website |
| 999 |
_c17602804 _d17602804 |
||